Wednesday, June 24, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 887 of 1,261
  1. US 8367690

    Aminopyridine derivatives having aurora a selective inhibitory action

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  2. US 8367074

    Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  3. US 8367810

    Purified plasmodium and vaccine compositions

    Sanaria Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  4. US 8367742

    Removable color layer for artificial nail coatings and methods therefore

    Creative Nail Design Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  5. US 8367841

    Processes for the preparation of 1,2,4-oxadiazole benzoic acids

    PTC THERAPEUTICS, INC. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  6. WO 2013014107

    SÉMULOPARINE POUR L'AMÉLIORATION DE LA SURVIE DE PATIENTS ATTEINTS D'UN CANCER

    AVENTIS PHARMA SA [FR] · Granted Jan 31, 2013 · Expires Jan 26, 2033

    granted
  7. WO 2013015774

    DIHYDROXY-CHLORINES GLYCO-SUBSTITUÉES ET CHLORINES BÊTA-FONCTIONNALISÉES POUR THÉRAPIE ANTIMICROBIENNE PHOTODYNAMIQUE

    BIOLITEC PHARMA MARKETING LTD [MY] · Granted Jan 31, 2013 · Expires Jan 26, 2033

    granted
  8. US 8362235

    Carboxamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  9. US 8362211

    Anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  10. US 8360765

    Systems and method for forming a coaxial implant

    Covidien LP · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  11. US 8362253

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  12. US 8362277

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  13. US 8361743

    Biological production of zeaxanthin and carotenoid biosynthesis control

    Aquapharm Bio-Discovery Ltd. · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  14. US 8361459

    Treatment of stroke and other acute neural degenerative disorders using postpartum-derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  15. US 8361982

    Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

    The Regents of the University of California · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  16. US 8361968

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  17. US 8361958

    Oximyl HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  18. US 8361508

    Endocytotic particles

    The Board of Regents of the University of Texas System · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  19. US 8361707

    Methods for detecting a Mycobacterium tuberculosis infection

    The United States of America—Department of Veterans Affairs · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  20. US 8361485

    Conditioned cell culture medium compositions and methods of use

    SkinMedica, Inc. · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  21. US 8361471

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  22. US 8361710

    MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-21

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  23. US 8362043

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted
  24. US 8362032

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.